Inventor · disambiguated record
Fabrizio Micheli
Also filed as: MICHELI FABRIZIO
34 granted patents·17 pending applications·137 citations·filing 1994–2024
96Inventor score
Files withGLAXO GROUP LTD19INDIVIOR UK LTD6BERTANI BARBARA3BONANOMI GIORGIO3CHRONOS THERAPEUTICS LTD3
Top patents by PatentIndex Score
51 records- 0187US7855298B2Azabicyclo (3.1.0.) hexane derivatives useful as modulators of dopamine D3 receptorsGLAXO GROUP LTD·Filed 2005·Granted Dec 21, 2010·11 cites·12 claims
- 0282US7799815B2Triazole derivatives as modulators of dopamine D3 receptorsGLAXO GROUP LTD·Filed 2006·Granted Sep 21, 2010·7 cites·15 claims
- 0380US7863299B2Triazolyl derivatives of azabicyclo [3.1.0] hexane as dopamine D3 receptor modulatorsGLAXO GROUP LTD·Filed 2006·Granted Jan 4, 2011·6 cites·12 claims
- 0480US7803820B23-triazolylthiaalkyl-3-azabicyclo (3-1-O) hexanes and their use as dopamine D3 receptor ligandsGLAXO GROUP LTD·Filed 2006·Granted Sep 28, 2010·5 cites·11 claims
- 0579US7727988B2Azabicyclo[3.1.0]hex-3-yl}alkyl)pyrimidinedioneGLAXO GROUP LTD·Filed 2007·Granted Jun 1, 2010·5 cites·6 claims
- 0678US7875643B2Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptorsGLAXO GROUP LTD·Filed 2006·Granted Jan 25, 2011·6 cites·10 claims
- 0777US7947683B23-(1,2,4-triazol-3-ylalkyl) azabicyclo (3.1.0) hexane derivatives as modulators of dopamine D3 receptorsGLAXO GROUP LIMTED·Filed 2006·Granted May 24, 2011·7 cites·10 claims
- 0877US5686461AIndole derivativesGLAXO WELLCOME SPA·Filed 1994·Granted Nov 11, 1997·36 cites·10 claims
- 0976US10000477B2Dopamine D3 receptor antagonist compoundsINDIVIOR UK LTD·Filed 2015·Granted Jun 19, 2018·2 cites·33 claims
- 1076US7253284B2Chemical compoundsGLAXO GROUP LTD·Filed 2002·Granted Aug 7, 2007·8 cites·1 claims
- 1173US7745458B2Azabicyclo (3, 1, 0) hexan derivatives useful as modulators of dopamine D3 receptorsGLAXO GROUP LTD·Filed 2006·Granted Jun 29, 2010·2 cites·11 claims
- 1273US7279474B2Substituted pyrrolo[2,3-d]pyrimidines as antagonists of the corticotropin releasing factor (CRF)GLAXO GROUP LTD·Filed 2002·Granted Oct 9, 2007·9 cites·12 claims
- 1372US10239870B2Dopamine D3 receptor antagonistsINDIVIOR UK LTD·Filed 2018·Granted Mar 26, 2019·1 cites·40 claims
- 1472US7462622B2Pyrrolo[2, 3-d] pyrimidine derivatives as corticotropin releasing factor antagonistsGLAXO GROUP LTD·Filed 2002·Granted Dec 9, 2008·8 cites·9 claims
- 1571US10273244B2Substituted hexahydropyrrolo[3,4-b]pyrroles and hexahydrocyclopenta[c]pyrroles as dopamine receptor modulatorsINDIVIOR UK LTD·Filed 2016·Granted Apr 30, 2019·1 cites·22 claims
- 1670US7807698B2Azabicyclo[3.1.0]hexane derivatives as modulators of the dopamine D3 receptorGLAXO GROUP LTD·Filed 2006·Granted Oct 5, 2010·1 cites·5 claims
- 1768US7329667B2CRF receptor antagonistsGLAXO GROUP LTD·Filed 2002·Granted Feb 12, 2008·4 cites·17 claims
- 1866US7273871B2Phenyl-5,6,6A,7,8,9-hexahydro-4H-1,4,9-triaza-phenalene derivatives as CRF antagonistsNEUROCRINE BIOSCIENCES INC·Filed 2002·Granted Sep 25, 2007·3 cites·6 claims
- 1963US10654842B2Dopamine D3 receptor antagonist compoundsINDIVIOR UK LTD·Filed 2019·Granted May 19, 2020·0 cites·20 claims
- 2059US8263782B2Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptorsARISTA LUCA·Filed 2009·Granted Sep 11, 2012·0 cites·22 claims
- 2156US5977136ATetrahydroquinolines as NMDA antagonistsGLAXO WELLCOME SPA·Filed 1996·Granted Nov 2, 1999·15 cites·16 claims
- 2254US2007219232A1Chemical CompoundsGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 2353US2025333405A1Antagonists of gpr39 proteinVASOCARDEA INC·Filed 2024·Application pending·0 cites
- 2451US10584135B2Substituted 3,6-diazabicyclo[3.2.0]heptanesINDIVIOR UK LTD·Filed 2019·Granted Mar 10, 2020·0 cites·19 claims
- 2550US8030322B2Spirocompounds useful as modulators for dopamine D3 receptorsGLAXO GROUP LTD·Filed 2007·Granted Oct 4, 2011·0 cites·5 claims
- 2649US8003638B27-pyrazolylbenzazepines having affinity for D3 receptorGLAXO GROUP LTD·Filed 2005·Granted Aug 23, 2011·0 cites·6 claims
- 2748US2023115176A1Complement Modulators and Related MethodsRA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2847US2009036461A1Use of Azabicyclo Hexane DerivativesHAMPRECHT DIETER·Filed 2006·Application pending·0 cites
- 2946US2010029740A1Azabicyclic compounds as serotonin, dopamine and norepinephrine re-uptake inhibitorsBONANOMI GIORGIO·Filed 2007·Application pending·0 cites
- 3045US7776904B2Azabicyclo [3.1.0] hexylphenyl derivatives as modulators of dopamine D3 receptorsGLAXO GROUP LTD·Filed 2006·Granted Aug 17, 2010·0 cites·10 claims
- 3145US2023174484A1Antagonists of gpr39 proteinUNIV OREGON HEALTH & SCIENCE·Filed 2021·Application pending·0 cites
- 3245US2006281786A1Compounds having activity at 5ht2c receptor and uses thereofHAMPRECHT DIETER·Filed 2004·Application pending·0 cites
- 3345US2009281135A13-azabicyclo [4. 1. 0] heptane derivatives for the treatment of depressionDI FABIO ROMANO·Filed 2007·Application pending·0 cites
- 3444US2007191457A1Compounds having activity at 5ht2c receptor and uses thereofBONANOMI GIORGIO·Filed 2004·Application pending·0 cites
- 3543US8163927B2Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptorsBERTANI BARBARA·Filed 2007·Granted Apr 24, 2012·0 cites·5 claims
- 3643US2006205788A1Compounds having activity at 5ht2c receptor and uses thereofDAMIANI FEDERICA·Filed 2004·Application pending·0 cites
- 3742US8222266B2Azabicyclo [3.1.0] hexyl derivatives as modulators of dopamine D3 receptorsBERTANI BARBARA·Filed 2007·Granted Jul 17, 2012·0 cites·7 claims
- 3842US2012196910A1Use of azabicyclo hexane derivativesHAMPRECHT DIETER·Filed 2012·Application pending·0 cites
- 3942US2005203079A1Compounds having affinity at 5ht2C receptor and use thereof in therapyGLAXO GROUP LTD·Filed 2003·Application pending·0 cites
- 4041US2007066640A1Heteroaryl-substituted pyrrolo'2,3-b1 pyridine derivatives as crf receptor antagonistsCASTIGLIONI EMILIANO·Filed 2004·Application pending·0 cites
- 4140US11660293B2Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonistsCHRONOS THERAPEUTICS LTD·Filed 2018·Granted May 30, 2023·0 cites·20 claims
- 4240US8178549B2Azabicyclo [3. 1. O] hexyl derivatives as modulators of dopamine D3 receptorsBERTANI BARBARA·Filed 2008·Granted May 15, 2012·0 cites·2 claims
- 4340US7989444B2Compounds having affinity for dopamine D3 receptor and uses thereofGLAXO GROUP LTD·Filed 2005·Granted Aug 2, 2011·0 cites·11 claims
- 4440US2008269195A1Compounds Having Affinity For the Dopamine D3 Receptor and Uses Thereof in MedicineBONANOMI GIORGIO·Filed 2005·Application pending·0 cites
- 4539US11773096B2Small-molecule PI5P4K alpha/beta inhibitors and methods of treatment using sameUNIV YALE·Filed 2019·Granted Oct 3, 2023·0 cites·13 claims
- 4639US2008139532A1Tetrahydrobenzazepine Derivatives as Modulators of Dopamine D3 Receptors (Antipsychotic Agents)GLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 4735US2009326011A1Azab i cyclo [3 . 1 . 0] hexane derivatives as dopamin d3 receptor modulatorsARISTA LUCA·Filed 2006·Application pending·0 cites
- 4833US10577361B2Dopamine D3 receptor antagonists having a morpholine moietyINDIVIOR UK LTD·Filed 2016·Granted Mar 3, 2020·0 cites·18 claims
- 4929US9920053B2N-(hetero)aryl-substituted heteroyclic derivatives useful for the treatment of diseases or conditions related to the central nervous systemCHRONOS THERAPEUTICS LTD·Filed 2015·Granted Mar 20, 2018·0 cites·21 claims
- 5028US2017260185A12-[bis(4-fluorophenyl)methyl]-2,7-diazaspiro[4.5]decan-10-one derivatives and related compounds as inhibitors of the human dopamine-active-transporter (dat) protein for the treatment of e.g. attention deficit disorder (add)SHIRE INT GMBH·Filed 2015·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Fabrizio Micheli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →